Addus HomeCare Corporation $ADUS Shares Bought by Punch & Associates Investment Management Inc.

Posted by on Jun 17th, 2026

Punch & Associates Investment Management Inc. grew its stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS – Free Report) by 27.4% in the fourth quarter, HoldingsChannel reports. The fund owned 182,954 shares of the company’s stock after buying an additional 39,299 shares during the quarter. Addus HomeCare makes up about 1.1% of Punch & Associates Investment Management Inc.’s portfolio, making the stock its 27th largest position. Punch & Associates Investment Management Inc.’s holdings in Addus HomeCare were worth $19,647,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of ADUS. Capital Research Global Investors increased its stake in shares of Addus HomeCare by 22.3% during the 4th quarter. Capital Research Global Investors now owns 1,469,752 shares of the company’s stock valued at $157,837,000 after acquiring an additional 268,192 shares during the last quarter. 8 Knots Management LLC purchased a new stake in shares of Addus HomeCare during the 3rd quarter worth about $6,075,000. Empowered Funds LLC grew its holdings in shares of Addus HomeCare by 186.1% during the 4th quarter. Empowered Funds LLC now owns 70,927 shares of the company’s stock worth $7,617,000 after purchasing an additional 46,137 shares during the period. Adage Capital Partners GP L.L.C. purchased a new stake in shares of Addus HomeCare during the 2nd quarter worth about $4,838,000. Finally, Vanguard Group Inc. grew its holdings in shares of Addus HomeCare by 2.9% during the 3rd quarter. Vanguard Group Inc. now owns 1,298,104 shares of the company’s stock worth $153,163,000 after purchasing an additional 36,674 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Stock Performance

Addus HomeCare stock opened at $94.71 on Wednesday. The stock has a market cap of $1.77 billion, a P/E ratio of 17.51, a price-to-earnings-growth ratio of 1.30 and a beta of 0.89. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.08. The stock has a 50 day moving average of $93.86 and a 200-day moving average of $102.86. Addus HomeCare Corporation has a 52 week low of $87.95 and a 52 week high of $124.43.

Addus HomeCare (NASDAQ:ADUS – Get Free Report) last posted its quarterly earnings results on Monday, May 4th. The company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.52 by $0.10. The business had revenue of $363.50 million for the quarter, compared to analyst estimates of $366.41 million. Addus HomeCare had a return on equity of 9.80% and a net margin of 6.89%.The business’s revenue was up 7.7% compared to the same quarter last year. During the same period in the prior year, the company posted $1.42 EPS. On average, analysts expect that Addus HomeCare Corporation will post 6.24 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on ADUS. Citizens Jmp reiterated a “market outperform” rating and set a $142.00 target price on shares of Addus HomeCare in a report on Monday, May 18th. Stephens decreased their target price on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating for the company in a report on Wednesday, February 25th. Royal Bank Of Canada reiterated an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a report on Wednesday, February 25th. Barclays decreased their target price on Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating for the company in a report on Friday, May 15th. Finally, Wall Street Zen cut Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Saturday, March 21st. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $131.00.

Check Out Our Latest Report on ADUS

About Addus HomeCare

(Free Report)

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

Featured Articles

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUS – Free Report).

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.